Following the incredible success of the first two International Conferences on Deprescribing, we look forward to once again bringing together clinicians, researchers, public advocates, students, and policymakers committed to deprescribing and medication appropriateness. Join us in Montréal, Canada, from April 27 to 29, 2026, for three days of learning, collaboration, and inspiration.
Why attend ICOD 2026?
ICOD 2026 offers a unique opportunity to:
Connect with leaders from around the world working to improve medication use;
Strengthen existing collaborations and spark new ones;
Learn about the latest evidence, innovations, and best practices in medication appropriateness and deprescribing;
Share and present your own academic or implementation work.
-
Aim
Create opportunities for researchers, clinicians, educators, policy makers and the public to work collaboratively and internationally to optimize medication appropriateness and facilitate deprescribing
Objectives
Attract and assemble deprescribing and medication appropriateness researchers, clinicians, educators, policy makers and members of the public from around the world
Engage trainees and early career researchers through active participation and mentorship
Facilitate networking and collaboration to build relationships and foster partnerships
Share the latest deprescribing and medication appropriateness research, education and policy approaches
Engage with new partners to expand the interprofessional and international horizon for deprescribing and medication appropriateness
-
Click here to see the invited speakers for ICOD 2026
-
Hotel Omni Mont-Royal in Montréal, Quebec, Canada (1050 Sherbrooke West, Montréal, QC H3A 2R6)
-
A block of rooms will be available for participants at the Hotel Omni Mont-Royal for the nights of April 26, 27, 28 and 29.
-
Are you a public or non-for-profit organization offering resources or services that support deprescribing and the appropriate use of medications?
Fill out the exhibitor form here to reserve a booth at ICOD 2026.
-
ICOD 2026 will be welcoming the following submissions: scientific abstracts for oral and poster presentations, workshops, panels, and seminars.
The abstract submission period is now closed.
The ICOD 2026 Submission Guidelines can be downloaded by clicking here.
-
Poster Format
All posters must be printed; electronic posters will not be available. Posters must fit within a 4 x 8 foot posterboard. Attendees are welcome to use any type of design as long as they stick to sizing requirements.Poster Setup and Presentation Schedule
You will be invited to present your poster on one day of the conference—either Tuesday, April 28 or Wednesday, April 29. The exact day and time will be confirmed in February. Dedicated poster viewing times will be scheduled in both the morning and afternoon each day. Details regarding poster setup will also be communicated in February.Best Student Poster Award
ICOD 2026 is pleased to offer a Best Student Poster Award for student-led scientific abstract presentations. Eligible posters are those for which the first author is identified as a student. Students will be invited to briefly present their poster, followed by a question period. Judging will take place at designated times. The specific schedule, presentation length, and evaluation rubric will be shared in February.Attendance
If you find that you are no longer able to attend the conference or present your poster, please inform us as soon as possible so we can make appropriate adjustments. -
Click here to discover the ICOD agenda.
Click here to access the ICOD Sessions Guide, which includes session descriptions outlining the learning objectives and intended audience for each session.
-
To stay updated, register to our newsletter by clicking here or follow us on Linkedin or Bluesky.
Meet Our Invited Speakers
Cynthia Boyd
Dr. Cynthia Boyd (MPH, MD) is the Director of the Division of Geriatric Medicine and Gerontology at the Johns Hopkins University School of Medicine, and co-director of the US Deprescribing Research Network (USDeN). She holds a joint appointment in Health Policy and Management and Epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Boyd’s career has focused on improving the health and well-being of older adults with multiple chronic conditions.
Clare Howard
Clare Howard (FFRPS, FRPharmS) is Clinical Lead for Medicines Optimisation and Polypharmacy Programme at Health Innovation Wessex . She previously served as Deputy Chief Pharmaceutical Officer for NHS England, where she advanced national medicines optimisation initiatives. Her work focuses on polypharmacy, medication safety, and innovation to improve patient outcomes.
Muhammad Mamdani
Dr. Muhammad Mamdani (PharmD, MA, MPH) is Clinical Lead for Artificial Intelligence at Ontario Health and Director of the University of Toronto Temerty Centre for Artificial Intelligence Research and Education in Medicine (T-CAIREM). His work is focused on applied artificial intelligence, health economics, drug policy, and health policy.
André Picard
André Picard is an award-winning journalist and health columnist for The Globe and Mail, one of Canada’s most widely read newspapers. He is the author of six bestselling books and has been invested into the Order of Canada for his extensive and impactful reporting on public health issues. In his work, Mr. Picard has explored many topics related to medication appropriateness, including the opioid crisis, the safety of natural health products, as well as polypharmacy and deprescribing among Canadian seniors.
Ross Upshur
Dr. Ross Upshur (MD, MA, MSc) graduated in medicine from McMaster University in 1986. His clinical research focused on complex chronic disease in adults with a focus on multimorbidity, polypharmacy and interprofessional approaches to management. In the early 2020’s he became what he was researching.